CONCENTRATED AQUEOUS LIQUID ANTACID COMPOSITIONS CONTAINING CERTAIN PHOSPHATE AND GLUCONATE SALTS
1,200,157. Pharmaceutical vehicle; antacid composition. SMITH KLINE & FRENCH LABORATORIES. 1 April, 1969 [5 April, 1968], No. 17074/69. Heading A5B. An aqueous pharmaceutical vehicle comprises a combination of monobasic calcium phosphate and at least one of sodium, potassium, calcium or magnesiu...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 1,200,157. Pharmaceutical vehicle; antacid composition. SMITH KLINE & FRENCH LABORATORIES. 1 April, 1969 [5 April, 1968], No. 17074/69. Heading A5B. An aqueous pharmaceutical vehicle comprises a combination of monobasic calcium phosphate and at least one of sodium, potassium, calcium or magnesium gluconate dissolved in water, wherein the phosphate and gluconate are each present in an amount from 0.5-7.0% W/V, provided that the total concentration of phosphate and gluconate is from 3-10% W/V. A liquid antacid composition comprises weight/volume of from 25-50% of solid antacid material suspended in an aqueous vehicle containing monobasic calcium phosphate and at least one of sodium, potassium calcium or magnesium gluconate. Conventional additives such as preservatives, flavours and solubilizers and anti-spasmodic agents or tranquilizers or glycine may also be present. |
---|